Related by context. All words. (Click for frequent words.) 70 Overactive Bladder 68 Renal Cell Carcinoma 68 Myelodysplastic Syndromes 67 Rheumatoid Arthritis RA 67 Lupus Nephritis 67 Allergic Rhinitis 67 Benign Prostatic Hyperplasia 67 Psychiatric Disorders 67 Acute Heart Failure 67 Chronic Lymphocytic Leukemia 67 Oral Fingolimod 66 Targeted Therapies 66 Severe Asthma 66 Clinical Trial Results 66 Investigational Treatment 66 Pulmonary Arterial Hypertension 66 Rheumatoid Arthritis Patients 66 Novel Mechanism 66 Fungal Infections 65 Urinary Incontinence 65 Immune Mediated 65 Heart Failure Patients 65 Prolongs Survival 65 Ischemic Stroke 65 Hepatitis C Virus 65 Meets Primary Endpoint 65 Systemic Lupus Erythematosus 65 Clinical Efficacy 64 Autoimmune Disease 64 Decitabine 64 Clinical Outcome 64 Drug Candidate 64 Rheumatoid 64 Renal Cancer 64 ACE Inhibitors 64 Peripheral Neuropathy 64 Investigational Drug 64 Natalizumab 64 Cannabinoid 64 Dyslipidemia 64 Emerging Therapies 64 Anti TNF 64 Chronic Sinusitis 64 Severe Sepsis 64 Diabetic Neuropathy 64 Bipolar Disorders 64 Castration Resistant Prostate Cancer 63 Atopic Dermatitis 63 Antiviral Therapy 63 Autoimmune Diseases 63 Generalized Anxiety Disorder 63 Psoriasis Patients 63 Orphan Diseases 63 JAK Inhibitor 63 Acute Renal Failure 63 Antiplatelet 63 Subgroup Analysis 63 Diagnostic Criteria 63 Inflammatory Disease 63 Chronic Myeloid Leukemia 63 Solid Tumors 63 Patients Treated With 63 Lung Cancer Drug 63 ASCO GI 63 Treatment Resistant 63 Disease Modifying 63 Shows Efficacy 63 Pulmonary Hypertension 63 Chronic Hepatitis B 63 Gastrointestinal Stromal Tumors 63 Asthma COPD 63 Relapsing Multiple Sclerosis 63 Insulin Resistance 63 Cancer Therapies 63 Osteoporosis Drug 63 Ischemic 63 Neuroprotective Effects 63 Rheumatoid Arthritis 63 Inflammatory Arthritis 63 Bipolar Depression 63 Nesiritide 63 Phase IIb Clinical Trial 63 Hormone Refractory Prostate Cancer 63 Beta Blockers 63 Knee Osteoarthritis 63 Bronchiectasis 63 Metastatic Prostate Cancer 63 Hepatocellular Carcinoma 63 Female Sexual Arousal 63 Treating Chronic 63 Improve Survival 63 Metabolic Disorder 63 Preclinical Data 63 Relapsed Multiple Myeloma 63 Antipsychotic 62 Systemic Sclerosis 62 Oral Mucositis 62 Pooled Analysis 62 Cancer Vaccines 62 Improves Outcomes 62 Schizophrenia Treatment 62 Inflammatory Markers 62 Multiple Myeloma Patients 62 Bladder Cancer 62 Acute Coronary Syndromes 62 Novel Therapies 62 Breast Cancer Recurrence 62 Restless Legs Syndrome 62 Prophylactic Treatment 62 Mouse Model 62 Adefovir 62 Fondaparinux 62 Diabetic Foot Ulcer 62 Minimally Invasive Treatment 62 Atypical Antipsychotics 62 Therapeutic Targets 62 Preclinical Models 62 ECTRIMS 62 Atypical Hemolytic Uremic Syndrome 62 Postmenopausal Osteoporosis 62 Patient Outcomes 62 Phase III Trial 62 Venous Thromboembolism 62 Chronic Constipation 62 Gastric Cancer 62 RNAi Therapeutics 62 Neoplasia 62 Progressive Multifocal Leukoencephalopathy 62 Low Dose 62 Chronic Prostatitis 62 Juvenile Idiopathic Arthritis 62 Previously Treated 62 Monoclonal Antibodies 62 Diabetic Retinopathy 62 Phase 2a Trial 62 Patients Receiving 62 Rheumatoid Arthritis Drug 62 Autologous Stem Cell Transplantation 62 Placebo Controlled Study 62 Osteoporosis Treatment 62 Biological Therapy 62 Critical Limb Ischemia 62 Patients Suffering 62 Acute Ischemic Stroke 62 Interstitial Cystitis 62 Safinamide 62 Multicenter Trial 62 Cimzia ® certolizumab pegol 62 Chronic Heart Failure 62 Fibromyalgia Syndrome 62 Sexual Dysfunction 62 Post Operative 62 Iron Overload 62 Growth Hormone Deficiency 62 Long Term Efficacy 62 Hematological Malignancies 62 Phase III Clinical Trial 62 Slow Progression 62 HCV Protease Inhibitor 62 Advanced Colorectal Cancer 62 Randomized Phase 61 Cardiometabolic 61 Enlarged Prostate 61 Novel Therapeutics 61 Effective Treatments 61 Novel Therapeutic 61 Renal Function 61 Interferon Beta 61 Treated Patients 61 Resistant Hypertension 61 Efficacious 61 Septic Shock 61 Treatment Outcome 61 Advanced Renal Cell 61 Dendritic Cells 61 Trigeminal Neuralgia 61 Malignant Melanoma 61 Metabolic Disorders 61 Cutaneous T 61 CNS Disorders 61 Kidney Transplant Patients 61 Prostate Cancer Treatment 61 Hyperlipidemia 61 Psoriasis Drug 61 Hypercholesterolemia 61 Lung Cancer Trial 61 Bivalirudin 61 Adjuvant Therapy 61 Complete Remission 61 Inflammatory Diseases 61 Diabetic Patients 61 Combination Treatment 61 Study Evaluating 61 Diabetic Foot Ulcers 61 Migraine Headaches 61 Neural Therapy 61 Improve Outcomes 61 Pediatric Patients 61 Liver Injury 61 Metastatic Renal Cell Carcinoma 61 Showed Significant 61 Golimumab 61 Ketorolac 61 Elderly Patients 61 Pirfenidone 61 Clinical Guideline 61 Patients Treated 61 Improved Survival 61 Diabetic Macular Edema 61 Kidney Function 61 Plaque Psoriasis 61 Stem Cell Treatment 61 Tyrosine Kinase Inhibitors 61 Major Depressive Disorder 61 Fibromyalgia Pain 61 Boceprevir 61 Survival Benefit 61 Thromboembolic 61 Advanced Melanoma 61 Phase 2b Clinical Trial 61 Pelvic Pain 61 Transdermal Patch 61 Aortic Stenosis 61 Hsp# Inhibitor 61 Treatment Reduces 61 Adjuvant Treatment 61 dual endothelin receptor antagonist 61 Tyrosine Kinase Inhibitor 61 Randomized Study 61 Gene Linked 61 Hemodialysis Patients 61 Peripheral Arterial Disease 61 Trodusquemine MSI 61 Etanercept 61 Myelofibrosis 61 Sleep Disturbances 61 Newly Diagnosed Multiple Myeloma 61 Cholesterol Lowering Drug 61 Cancer Immunotherapy 61 Antifungals 61 Ulcerative Colitis 60 Respiratory Disorders 60 Antipsychotic Medications 60 Inflammatory Bowel Diseases 60 Thrombotic 60 Liver Failure 60 Malignancies 60 GABITRIL 60 Investigational Compound 60 Drug Shows Promise 60 Cardiovascular Mortality 60 Eye Diseases 60 Psoriatic Arthritis 60 Dose Escalation 60 Suicidality 60 Prospective Multicenter 60 Antithrombotic 60 Disease Progression 60 Anticoagulant 60 Fracture Risk 60 Drug Prevents 60 Treatment Algorithm 60 Orally Active 60 Leukemias 60 Fabry Disease 60 Cardiotoxicity 60 Aliskiren 60 Infliximab 60 Hyperuricemia 60 Medical Oncology ESMO 60 ISPOR 60 Lipodystrophy 60 Obese Patients 60 Contrast Agents 60 Corticosteroids 60 Prospective Randomized 60 Beta Blocker 60 Cachexia 60 Neoplasms 60 Chronic Wounds 60 Irritable Bowel Syndrome IBS 60 Lung Cancer Survival 60 Epilepsy Drug 60 Tocilizumab 60 Hematological 60 Improves Survival 60 Autoimmune Disorders 60 Study Showed 60 Cognitive Impairment 60 Movement Disorder 60 Novel Antibiotic 60 Erectile Dysfunction Drug 60 Novel Treatments 60 Antitumor Activity 60 Acute Pain 60 Gastrointestinal GI 60 Thyroid Hormone 60 Lupus Drug 60 Demonstrates Potential 60 chronic rhinosinusitis CRS 60 Topical Treatment 60 Adjuvant Breast Cancer 60 Reflux Disease 60 Chronic Hepatitis C 60 Osteoarthritis Pain 60 Ankylosing Spondylitis 60 Blood Cancers 60 Neuropathy 60 Nocturia 60 Omalizumab 60 Significantly Improved 60 Beneficial Effects 60 Tiotropium 60 Anticoagulants 60 Protease Inhibitors 60 Dupuytren Contracture 60 Therapeutic Potential 60 Surgical Procedures 60 Anticonvulsants 60 Early Diagnosis 60 Pulmonary Arterial Hypertension PAH 60 Bone Metastases 60 Metastatic Colorectal Cancer 60 Well Tolerated 60 Mitral Regurgitation 60 Idiopathic Pulmonary Fibrosis 60 Percutaneous Tibial Nerve Stimulation 60 HER2 Positive Breast Cancer 60 Treatment Naive Patients 60 Disease Modification 60 Anthracycline 60 See CLINICAL PHARMACOLOGY 60 Laryngeal Cancer 60 Metastatic Cancer 60 Arthritis Drug 60 Hormone Receptor Positive 60 Recombinant Human 60 Breast Cancer Treatment 60 Anticancer Activity 60 Unmet Medical 60 Metabolic Disease 60 Signaling Pathway 60 Rhinosinusitis 60 Successfully Treated 60 Patient Enrollment 60 Cardiovascular Events 60 Statistically Significant 60 Nicotine Vaccine 60 Hematological Cancers 60 Relapsing Remitting Multiple Sclerosis 60 Phase 2b Study 60 Therapy Shows Promise 60 Renal Anemia 60 Cardiovascular Outcomes 60 Diabetic Ulcers 59 Treatment Shows Promise 59 Bipolar Mania 59 Protein Involved 59 Anti Inflammatory Drugs 59 Systemic Lupus Erythematosus SLE 59 AA Amyloidosis 59 Gastrointestinal Disorders 59 Clostridium difficile Infection 59 Pharmacologic 59 Investigational Agent 59 Genetic Variant 59 Commonly Used 59 Soft Tissue Sarcoma 59 Adalimumab 59 Late Breaker 59 Malignant Lymphoma 59 Chronic Bronchitis 59 FDA Approvals 59 Neuroprotection 59 Glatiramer Acetate 59 Lung Injury 59 Arrhythmias 59 Lumbar Spine 59 Antiepileptic Drugs 59 Unfractionated Heparin 59 Chemotherapy induced 59 Refractory Angina 59 FDA Okays 59 CIPN 59 Angioedema 59 HIV Infection 59 Thyroid Cancer 59 Osteoarthritis Patients 59 Neuropathic 59 Complicated Skin 59 Statin Drugs 59 Menopausal Symptoms 59 CNS Therapeutics 59 Bare Metal Stent 59 Diabetic Neuropathic Pain 59 Symptom Relief 59 Reduces Mortality 59 Cancer Stem Cells 59 Brain Metastases 59 Controlled Trial 59 Asthma Treatment 59 Hematologic 59 Placebo Controlled Trial 59 Demonstrates Positive 59 Enzyme Replacement Therapy 59 Dasatinib 59 retinal vein occlusion 59 Parkinson Disease PD 59 Renal Cell Cancer 59 Neurostimulation 59 Advanced Pancreatic Cancer 59 Drug Eluting Stents 59 Hepatitis C Genotype 59 Fewer Side Effects 59 Non Steroidal Anti Inflammatory 59 Hormone Therapy 59 LHON 59 Uterine Fibroids 59 KRN# 59 Pemphigus 59 Sipuleucel T 59 Musculo Skeletal Disorders 59 Meta Analysis 59 Stent Thrombosis 59 Erythropoietic 59 ASH Annual Meeting 59 Angiogenic 59 Paroxysmal Nocturnal Hemoglobinuria PNH 59 Osteoporosis Drugs 59 Generic Versions 59 Autoimmune 59 Gout Drug 59 Clinical Trial Data 59 TB Vaccine 59 Demonstrates Efficacy 59 Hematology Meeting 59 Adjunctive Therapy 59 tocilizumab 59 Extracorporeal Shock Wave 59 Interferon Alpha 59 Bosutinib 59 Combination Therapy 59 Restless Legs Syndrome RLS 59 Postherpetic Neuralgia 59 Effectively Treats 59 Inflammatory Bowel Disease 59 acute PAO 59 Follicular Lymphoma 59 Chronic Lymphocytic Leukemia CLL 59 Biologic Therapy 59 Peer Reviewed Journal 59 Blood Pressure Drug 59 Aneurysm Repair 59 Hematopoietic Stem Cell Transplantation 59 Acute Myocardial Infarction 59 Lowers Risk 59 Cell Transplant 59 Brain Tumors 59 Cilostazol 59 Novel Oral 59 Delayed Graft Function 59 IND Application 59 Immunosuppressant 59 Initiate Phase 59 Malignant Glioma 59 Anti Tumor 59 Valvular Heart Disease 59 Drug Fails 59 Nilotinib 59 Relapsed Refractory 59 Analgesics 59 Postmenopausal Women 59 Anti Tumor Activity 59 Anticancer Drug 59 Anti Angiogenesis 59 Synthetic Peptide 59 Lung Cancer Patients 59 Social Phobia 59 Milnacipran 59 orally inhaled migraine 59 ALS MND 59 Major Depressive Disorder MDD 59 Arterial Hypertension 59 Serious Infections 59 Lubiprostone 59 Antiangiogenic 59 Newly Diagnosed 59 Phase III Trials 59 Antiplatelet Therapy 59 Metabolic Endocrinology 59 Mortality Risk 59 Hepatic Encephalopathy 59 Liver Disease 59 Initiates Phase III 59 Peripheral Artery Disease 59 Sustained Release 59 Gaucher Disease 59 Randomized Controlled Trials 59 Pain Therapy 59 Anti Clotting Drug 59 Improved Outcomes 59 Betaferon R 59 Multiple Sclerosis ECTRIMS 59 constipation OIC 59 Adult Stem Cell Therapy 59 Cinacalcet 59 Neurodegenerative 59 Epidermal Growth Factor Receptor 59 Diabetic Kidney Disease 59 ST Elevation Myocardial 59 Pivotal Phase III 59 Biomarker Study 59 Schizophrenia Drug 59 Orthostatic Hypotension 59 Treatment Algorithms 59 Malignant Mesothelioma 59 Carotid Stenting 59 Peritoneal Dialysis 59 Candesartan 59 Pathogenesis 59 Potent Antiviral Activity 59 Migraine Drug 59 Tesamorelin 59 Initiates Clinical Trial 59 Pelvic Organ Prolapse 59 Receives Orphan Drug Designation 59 Anemia Drug 59 Teriparatide 59 Polyneuropathy 59 Vertebral Compression Fractures 59 Chronic HCV 59 Valve Replacement 59 Cognitive Deficits 59 Frozen Shoulder Syndrome 59 EFNS 59 Shows Promise Against 59 Diuretic 59 Therapy Improves 59 Cognitive Function 59 Drug Resistant 59 Proves Effective 59 Tasigna nilotinib 59 Inhaled Corticosteroids 58 Clinical Trial Evaluating 58 HeFH 58 Bazedoxifene 58 Oral Presentations 58 Peginterferon 58 Panic Disorder 58 Thrombus 58 Atomoxetine 58 Neovascular Age Related Macular 58 Chronic Rhinosinusitis 58 Desvenlafaxine Succinate 58 Combo Therapy 58 Antidepressant Drug 58 Breast Cancer Metastasis 58 INVEGA ® 58 Adjunctive Treatment 58 Advanced Prostate Cancer 58 Is Well Tolerated 58 Fibrates 58 Lower Urinary Tract 58 Often Misdiagnosed 58 Pfizer Lyrica 58 Statin Therapy 58 Non Invasive Treatment 58 Desvenlafaxine 58 Arch Neurol 58 Hepatitis B Vaccine 58 League Against Rheumatism 58 Renal Artery 58 Chronic Myelogenous Leukemia 58 Visceral Fat 58 Study Demonstrates 58 Elagolix 58 Patients Enrolled 58 Colorectal Cancer Patients 58 Female Urology 58 Insulin Therapy 58 Renal Impairment 58 atypical Hemolytic Uremic Syndrome 58 Uric Acid 58 Lymphoid 58 Neck Cancer 58 Oligonucleotides 58 ST Segment Elevation 58 Cancers Symposium 58 Cholesterol Drugs 58 Erythropoiesis Stimulating Agents ESAs 58 Diagnosis Treatment 58 Capecitabine 58 Multicenter Study 58 Diabetic Nephropathy 58 Febrile Neutropenia 58 Antipsychotic Drug 58 Anticancer Drugs 58 Hepatitis C Infection 58 Knee Arthritis 58 Newly Diagnosed Patients 58 Poster Presentation 58 Stakeholder Insight 58 Abdominal Pain 58 Granted Orphan Drug 58 Targeted Anticancer Therapies 58 Kinase Inhibitors 58 Completes Patient Enrollment 58 Mesothelioma Treatment 58 Bone Fracture 58 Platelet Aggregation 58 Genetic Basis 58 Receptor Agonist 58 Chronic Cough 58 Slows Progression 58 Transdermal Delivery 58 Vasomotor Symptoms 58 Neoadjuvant Chemotherapy 58 Stomatitis 58 International OARSI 58 Lenalidomide 58 Initiate Clinical Trial 58 ICAAC IDSA 58 Milestone Payment 58 Dysmenorrhea 58 Vulnerable Plaque 58 Back Pain Sufferers 58 Therapy Reduces 58 Community Acquired Pneumonia 58 Critically Ill Patients 58 Gastrointestinal Cancer 58 Protein Therapeutics 58 Adjunctive 58 Left Ventricular 58 Positive Opinion 58 Hospital Acquired Pneumonia 58 Differential Diagnosis 58 Treatable 58 Chronic Fatigue Syndrome CFS 58 Unresectable 58 Analgesic 58 Novel Compound 58 Tumor Growth 58 Genes Identified 58 Romiplostim 58 Tigecycline 58 Immunologic 58 Single Dose 58 Periodontal Disease 58 Sumatriptan 58 Alternative Treatments 58 Demonstrates Significant 58 Bevacizumab 58 Peripheral Arterial 58 Respiratory Virus 58 Treating Depression 58 Medication Errors 58 Lower Extremity 58 Immunosuppression 58 Dyloject TM 58 Myelodysplastic Syndrome MDS 58 Progenitor Cells 58 Antiepileptic Drug 58 Serdolect ® 58 Brentuximab Vedotin SGN 58 Mantle Cell Lymphoma 58 Hepatitis C Treatment 58 Kinase Inhibitor 58 Anticancer Agent 58 Gene Mutation 58 Critical Limb Ischemia CLI 58 Myeloma Patients 58 Anti Angiogenic 58 Vertebroplasty 58 Genes Predict 58 Epoetin Alfa 58 Therapeutics TCT scientific 58 Phase III Clinical Trials 58 Image Guided 58 Genetic Variation 58 Treatment Regimen 58 Receives Positive Opinion 58 Magnetic Stimulation 58 Adjuvant Chemotherapy 58 Venous Thrombosis 58 First Patient Enrolled 58 abacavir Ziagen 58 Ustekinumab 58 Rectal Cancer 58 Cyclooxygenase 2 58 Diabetes Complications 58 antithrombotics 58 Thrombolytic Therapy 58 Demonstrated Significant 58 Infected Patients 58 Premature Aging 58 overactive bladder syndrome 58 Pegylated Interferon 58 Subtypes 58 Radiofrequency Ablation 58 Renal Failure 58 Acute Coronary Syndrome 58 Anticancer Agents 58 Phase 2a Study 58 Retroviral 58 Intervention Effectiveness 58 Fixed Dose Combination 58 Multicenter Phase 58 Novel Approaches 58 Initiates Clinical 58 Surgical Treatment 58 Reduced Risk 58 Mycophenolate Mofetil 58 Therapies 58 Anti Depressant 58 Receives Marketing Authorization 58 Artery Disease 58 Preclinical Study 58 Atrial Fibrillation AF 58 Capsule Endoscopy 58 INTEGRILIN R 58 Anxiety Depression 58 Phase III Pivotal Trial 58 Patient Treated 58 Pivotal Phase 58 Levels Linked 58 post herpetic 58 Arterial Disease 58 Randomized Double Blind Placebo 58 Invasive Breast Cancer 58 Genes Involved 58 Tumor Targeting 58 Enalapril 58 Pivotal Trial 58 Benign Prostatic Hyperplasia BPH 57 Bone Marrow Cells 57 Eculizumab 57 Pre Eclampsia 57 Peptic Ulcer 57 Therapeutic Effects 57 Esophageal 57 Tacrolimus 57 Secondary Hyperparathyroidism 57 Influenza Vaccines 57 Pertuzumab 57 Cardiac Rhythm 57 Tumor Response 57 Intracerebral Hemorrhage 57 Diabetic Peripheral Neuropathy 57 Tumor Microenvironment 57 Sustained Reduction 57 Significantly Improves 57 Chronic Inflammatory 57 Phase Ib Clinical Trial 57 GW# [003] 57 Neck Pain 57 Mitral Valve Repair 57 Successfully Treats 57 Psoriasis 57 Neuromuscular Diseases 57 Diabetes Epidemic 57 PEGylated interferon beta 1a 57 Placebo Effect 57 Anticoagulation 57 Bioequivalence 57 Lamotrigine 57 Efficacy Trial 57 Chemotherapy Induced 57 paroxetine Paxil 57 Diabetic Foot 57 Acute Stroke 57 adalimumab Humira 57 Hypertensive Patients 57 Signaling Pathways 57 Toxicogenomics 57 Ocrelizumab 57 Genes Linked 57 Premature Ejaculation 57 Clinical Practice Guidelines 57 Viral Infections 57 Iron Deficiency Anemia 57 Percutaneous Coronary Intervention 57 Shown Effective 57 Valsartan 57 Rotigotine 57 Ambrisentan 57 Bipolar Disorder 57 overactive bladder symptoms 57 Protein Synthesis 57 Ramelteon 57 Ecallantide 57 Patients Undergoing 57 Thromboembolism 57 rasagiline tablets 57 Myelodysplastic Syndrome 57 immunomodulatory agents 57 Microplasmin 57 Randomized Clinical Trials 57 Tablet Formulation 57 Raptiva R 57 Cancer Treatments 57 FDA Approves Drug 57 Diastolic Heart Failure 57 Therapeutic Approaches 57 Invasive Fungal Infections 57 painful diabetic neuropathy 57 Sleep Disorder 57 Infarct 57 Personalised Medicine 57 Pivotal Clinical Trial 57 Antibacterials 57 Cervical Spine 57 Rheumatologists 57 Reminyl galantamine 57 Preterm Birth 57 Regenerative Cells 57 Respiratory Distress 57 Hepatotoxicity 57 Predict Risk 57 Heart Transplant Recipients 57 Smooth Muscle 57 Duloxetine 57 Tumor Markers 57 Inhaled Nitric Oxide 57 psoriatic arthritis PsA 57 Levoleucovorin 57 Seasonal Influenza Vaccine 57 Cholesterol Levels 57 Etiology 57 oropharyngeal candidiasis 57 Risk Stratification 57 Prostate Biopsy 57 STELARA TM 57 entitled Synergistic 57 von Willebrand Disease 57 Medication Adherence 57 Drug Combo 57 Cardiovascular Disease 57 Intravesical 57 Oral Presentation 57 Clinical Practice Guideline 57 Cocaine Addiction 57 Non Responders 57 Chronic Pelvic Pain 57 Double Blind Placebo 57 Palonosetron 57 Endometrial Cancer 57 Phase IIb Trial 57 Anticancer 57 Irritable Bowel 57 Cytotoxicity 57 Aripiprazole 57 Genetic Variations 57 Bone Marrow Stem Cells 57 Kidney Transplants 57 Chemoradiation 57 Localized Prostate Cancer 57 Nymox NX 57 Replacement Therapy 57 Skeletal Muscle 57 Mucositis 57 Aryplase 57 osteoporotic vertebral fractures 57 Motility 57 Nerve Pain 57 Chronic Inflammation 57 External Defibrillators 57 Stress Urinary Incontinence 57 Degarelix 57 Potentially Fatal 57 Galantamine 57 Uterine Fibroid Embolization 57 Genes Associated 57 Coronary Artery Bypass Graft 57 Ranolazine 57 ERA EDTA 57 II Clinical Trial 57 Schizophrenia 57 Monotherapy 57 STRIDE PD 57 Poster Discussion 57 Drug Eluting 57 MPS VI 57 Fecal Incontinence 57 Phase 2b Trial 57 Antidepressants Linked 57 Short Stature 57 RNAi Therapeutic 57 Long Term Survival 57 Frovatriptan 57 Bone Marrow Transplants 57 Stent Placement 57 Asthma Symptoms 57 Monoclonal Antibody 57 Phase 2a Clinical Trial 57 Research www. elsevier.com 57 Iron Deficiency 57 Erosive Esophagitis 57 Chronic Pain 57 Vascular Disease 57 CROI 57 Pemphigus Vulgaris 57 Ischaemic 57 Anti Infectives 57 Bucindolol 57 Immunomedics Announces 57 Physical Function 57 Allergies Asthma 57 Spinal Manipulation 57 Adverse Event 57 Double Blind Randomized 57 Onychomycosis 57 Neurological Diseases 57 Fingolimod 57 Antibody Therapy 57 Liver EASL 57 Ovarian Cancer Treatment 57 Lung Transplantation 57 Chronic Liver Disease 57 Premenopausal Women 57 Naive Patients 57 Preclinical Studies 57 ACTEMRA TM 57 OARSI 57 Demonstrate Significant 57 NICE Recommends 57 ECCO ESMO 57 Ozarelix 57 Psychiatric Illness 57 Thrombosis 57 Successfully Completes Phase 57 Hematologic Oncology 57 Psychodynamic Psychotherapy 57 Cerebral Aneurysms 57 PsA 57 Fulvestrant 57 Atypical Antipsychotic 57 Insulin Delivery 57 Sifrol ® 57 Corneal Transplant 57 Muscle Wasting 57 Risperdal Zyprexa 57 transthyretin TTR mediated amyloidosis 57 Clinical Trials Review 57 Certain Cancers 57 Lilly Cymbalta 57 entitled Formulary Advantages 57 Patellofemoral 57 Low Incidence 57 Blood Thinning 57 Treatment Experienced 57 Telbivudine 57 Metastatic Melanoma 57 Fibromyalgia Syndrome FMS 57 Sapacitabine 57 interferon gamma 1b 57 Hepatitis C Patients 57 Coronary Revascularization 57 relapsing multiple sclerosis 57 Vicriviroc 57 rheumatoid arthritis psoriatic arthritis 57 Stress Incontinence 57 Premature Infants 57 Islet Transplant 57 adult chronic ITP 57 Detrol Detrol LA 57 Cholesterol Drug 57 Clinically Tested 57 Remote Patient Monitoring 57 Trandolapril 57 Gene Mutation Linked 57 Treat Anemia 57 Randomized Clinical Trial 57 Innate Immunity 57 Spinal Fusion 57 Alemtuzumab 57 Postmarketing 57 Study Shows Significant 57 systemic fungal infections 57 Combination REOLYSIN R 57 GI motility disorders 57 Sepsis 57 Oral Spray 57 Darbepoetin Alfa 57 Bone Fractures 57 Tasimelteon 57 Infarction 57 Shows Promising 57 Amniotic Fluid 56 Intraocular 56 Chronic Renal Failure 56 Breast Cancer Patients 56 Adverse Effects 56 Novel Small Molecule 56 familial amyloidotic polyneuropathy FAP 56 Embolization 56 AVAPRO 56 JAK2 Inhibitor 56 Genetic Markers 56 Less Invasive